17 research outputs found
Genetic Disruption of Both Tryptophan Hydroxylase Genes Dramatically Reduces Serotonin and Affects Behavior in Models Sensitive to Antidepressants
The neurotransmitter serotonin (5-HT) plays an important role in both the peripheral and central nervous systems. The biosynthesis of serotonin is regulated by two rate-limiting enzymes, tryptophan hydroxylase-1 and -2 (TPH1 and TPH2). We used a gene-targeting approach to generate mice with selective and complete elimination of the two known TPH isoforms. This resulted in dramatically reduced central 5-HT levels in Tph2 knockout (TPH2KO) and Tph1/Tph2 double knockout (DKO) mice; and substantially reduced peripheral 5-HT levels in DKO, but not TPH2KO mice. Therefore, differential expression of the two isoforms of TPH was reflected in corresponding depletion of 5-HT content in the brain and periphery. Surprisingly, despite the prominent and evolutionarily ancient role that 5-HT plays in both vertebrate and invertebrate physiology, none of these mutations resulted in an overt phenotype. TPH2KO and DKO mice were viable and normal in appearance. Behavioral alterations in assays with predictive validity for antidepressants were among the very few phenotypes uncovered. These behavioral changes were subtle in the TPH2KO mice; they were enhanced in the DKO mice. Herein, we confirm findings from prior descriptions of TPH1 knockout mice and present the first reported phenotypic evaluations of Tph2 and Tph1/Tph2 knockout mice. The behavioral effects observed in the TPH2 KO and DKO mice strongly confirm the role of 5-HT and its synthetic enzymes in the etiology and treatment of affective disorders
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study
Introduction:
The multiorgan impact of moderate to severe coronavirus infections in the post-acute phase is still poorly understood. We aimed to evaluate the excess burden of multiorgan abnormalities after hospitalisation with COVID-19, evaluate their determinants, and explore associations with patient-related outcome measures.
Methods:
In a prospective, UK-wide, multicentre MRI follow-up study (C-MORE), adults (aged ā„18 years) discharged from hospital following COVID-19 who were included in Tier 2 of the Post-hospitalisation COVID-19 study (PHOSP-COVID) and contemporary controls with no evidence of previous COVID-19 (SARS-CoV-2 nucleocapsid antibody negative) underwent multiorgan MRI (lungs, heart, brain, liver, and kidneys) with quantitative and qualitative assessment of images and clinical adjudication when relevant. Individuals with end-stage renal failure or contraindications to MRI were excluded. Participants also underwent detailed recording of symptoms, and physiological and biochemical tests. The primary outcome was the excess burden of multiorgan abnormalities (two or more organs) relative to controls, with further adjustments for potential confounders. The C-MORE study is ongoing and is registered with ClinicalTrials.gov, NCT04510025.
Findings:
Of 2710 participants in Tier 2 of PHOSP-COVID, 531 were recruited across 13 UK-wide C-MORE sites. After exclusions, 259 C-MORE patients (mean age 57 years [SD 12]; 158 [61%] male and 101 [39%] female) who were discharged from hospital with PCR-confirmed or clinically diagnosed COVID-19 between March 1, 2020, and Nov 1, 2021, and 52 non-COVID-19 controls from the community (mean age 49 years [SD 14]; 30 [58%] male and 22 [42%] female) were included in the analysis. Patients were assessed at a median of 5Ā·0 months (IQR 4Ā·2ā6Ā·3) after hospital discharge. Compared with non-COVID-19 controls, patients were older, living with more obesity, and had more comorbidities. Multiorgan abnormalities on MRI were more frequent in patients than in controls (157 [61%] of 259 vs 14 [27%] of 52; p<0Ā·0001) and independently associated with COVID-19 status (odds ratio [OR] 2Ā·9 [95% CI 1Ā·5ā5Ā·8]; padjusted=0Ā·0023) after adjusting for relevant confounders. Compared with controls, patients were more likely to have MRI evidence of lung abnormalities (p=0Ā·0001; parenchymal abnormalities), brain abnormalities (p<0Ā·0001; more white matter hyperintensities and regional brain volume reduction), and kidney abnormalities (p=0Ā·014; lower medullary T1 and loss of corticomedullary differentiation), whereas cardiac and liver MRI abnormalities were similar between patients and controls. Patients with multiorgan abnormalities were older (difference in mean age 7 years [95% CI 4ā10]; mean age of 59Ā·8 years [SD 11Ā·7] with multiorgan abnormalities vs mean age of 52Ā·8 years [11Ā·9] without multiorgan abnormalities; p<0Ā·0001), more likely to have three or more comorbidities (OR 2Ā·47 [1Ā·32ā4Ā·82]; padjusted=0Ā·0059), and more likely to have a more severe acute infection (acute CRP >5mg/L, OR 3Ā·55 [1Ā·23ā11Ā·88]; padjusted=0Ā·025) than those without multiorgan abnormalities. Presence of lung MRI abnormalities was associated with a two-fold higher risk of chest tightness, and multiorgan MRI abnormalities were associated with severe and very severe persistent physical and mental health impairment (PHOSP-COVID symptom clusters) after hospitalisation.
Interpretation:
After hospitalisation for COVID-19, people are at risk of multiorgan abnormalities in the medium term. Our findings emphasise the need for proactive multidisciplinary care pathways, with the potential for imaging to guide surveillance frequency and therapeutic stratification
The inside story: Health effects of indoor air quality on children and young people
The Royal College of Paediatrics and Child Health and the Royal College of Physicians wish to support clinicians by providing the tools to advocate for healthy air for their patients.
The United Nations Convention on the Rights of the Child sets out clear guidance to protecting the rights of children and young people, including a childās right to the best possible health (Article 24) and the right to a good standard of living. Government must support this where the family is unable (Article 27). Unicef also consider1 that clean air is a right for all children. The Royal Colleges vigorously advocate for a healthy environment at the population level and in local communities, especially where socioeconomic circumstances limit the choice of where people can live, and which school children attend.
When there is mounting evidence to establish a potential cause of preventable ill health Royal Colleges can advocate for change, including regulatory change. This has happened before for tobacco smoking, asbestos, outdoor air pollution, and damp, mouldy homes. The focus of this report is about the emerging evidence on indoor air pollution, and sets out recommendations aimed at preventing poor indoor air quality affecting the health and well-being of children
Discovery and Characterization of Novel Tryptophan Hydroxylase Inhibitors That Selectively Inhibit Serotonin Synthesis in the Gastrointestinal Tract
In-plane Thermal Conductivity Measurement with Nanosecond Grating Imaging Technique
<p>We develop a nanosecond grating imaging (NGI) technique to measure in-plane thermal transport properties in bulk and thin-film samples. Based on nanosecond time-domain thermoreflectance (ns-TDTR), NGI incorporates a photomask with periodic metal strips patterned on a transparent dielectric substrate to generate grating images of pump and probe lasers on the sample surface, which induces heat conduction along both cross- and in-plane directions. Analytical and numerical models have been developed to extract thermal conductivities in both bulk and thin-film samples from NGI measurements. This newly developed technique is used to determine thickness-dependent in-plane thermal conductivities (<i>Īŗ<sub>x</sub></i>) in Cu nano-films, which agree well with the electron thermal conductivity values converted from four-point electrical conductivity measurements using the WiedemamnāFranz law, as well as previously reported experimental values. The <i>Īŗ<sub>x</sub></i> measured with NGI in an 8Ā nm x 8Ā nm GaAs/AlAs superlattice (SL) is about 10.2Ā W/mā
K, larger than the cross-plane thermal conductivity (8.8Ā W/mā
K), indicating the anisotropic thermal transport in the SL structure. The uncertainty of the measured <i>Īŗ<sub>x</sub></i> is about 25% in the Cu film and less than 5% in SL. Sensitivity analysis suggests that, with the careful selection of proper substrate and interface resistance, the uncertainty of <i>Īŗ<sub>x</sub></i> in Cu nano-films can be as low as 5%, showing the potential of the NGI technique to determine <i>Īŗ<sub>x</sub></i> in thin films with improved accuracy. By simply installing a photomask into ns-TDTR, NGI provides a convenient, fast, and cost-effective method to measure the in-plane thermal conductivities in a wide range of structures and materials.</p
Characterization of PTPRG in Knockdown and Phosphatase-Inactive Mutant Mice and Substrate Trapping Analysis of PTPRG in Mammalian Cells
<div><p>Receptor tyrosine phosphatase gamma (PTPRG, or RPTPĪ³) is a mammalian receptor-like tyrosine phosphatase which is highly expressed in the nervous system as well as other tissues. Its function and biochemical characteristics remain largely unknown. We created a knockdown (KD) line of this gene in mouse by retroviral insertion that led to 98ā99% reduction of RPTPĪ³ gene expression. The knockdown mice displayed antidepressive-like behaviors in the tail-suspension test, confirming observations by Lamprianou et al. 2006. We investigated this phenotype in detail using multiple behavioral assays. To see if the antidepressive-like phenotype was due to the loss of phosphatase activity, we made a knock-in (KI) mouse in which a mutant, RPTPĪ³ C1060S, replaced the wild type. We showed that human wild type RPTPĪ³ protein, expressed and purified, demonstrated tyrosine phosphatase activity, and that the RPTPĪ³ C1060S mutant was completely inactive. Phenotypic analysis showed that the KI mice also displayed some antidepressive-like phenotype. These results lead to a hypothesis that an RPTPĪ³ inhibitor could be a potential treatment for human depressive disorders. In an effort to identify a natural substrate of RPTPĪ³ for use in an assay for identifying inhibitors, āsubstrate trappingā mutants (C1060S, or D1028A) were studied in binding assays. Expressed in HEK293 cells, these mutant RPTPĪ³s retained a phosphorylated tyrosine residue, whereas similarly expressed wild type RPTPĪ³ did not. This suggested that wild type RPTPĪ³ might auto-dephosphorylate which was confirmed by an <em>in vitro</em> dephosphorylation experiment. Using truncation and mutagenesis studies, we mapped the auto-dephosphorylation to the Y1307 residue in the D2 domain. This novel discovery provides a potential natural substrate peptide for drug screening assays, and also reveals a potential functional regulatory site for RPTPĪ³. Additional investigation of RPTPĪ³ activity and regulation may lead to a better understanding of the biochemical underpinnings of human depression.</p> </div
RPTPĪ³ dephosphorylated itself in vitro.
<p>Wild type RPTPĪ³ or RPTPĪ³ C1060S plasmids were transiently transfected into HEK293F and isolated from lysates with anti c-myc/protein G sepharoses. RPTPĪ³ wild type or C1060S on the protein G sepharose was denatured in 8 M urea to linearized protein as substrates for reaction following. The Purified RPTPĪ³ wild type, C1060s sepharose beads was then incubated with recombinant, active purified RPTPĪ³ cyto enzymes in assay buffer with urea at a final concentration of 0.375 M. Lanes 1 and 2 are RPTPĪ³ WT and RPTPĪ³ C1060S on protein G sepharose in a mock reaction without phosphatase in the same buffer, and lanes 1ā²and 2ā² are RPTPĪ³ wild type and RPTPĪ³ C1060S reacted with RPTPĪ³ cytoplasmic region as phosphatase. Samples were subjected to western blot analysis using anti-phosphotyrosine 4G10 mAb. The densitometry of each band was determined to estimate the extent of removal of phosphotyrosine on the protein. The reacted IgG heavy chain bands were used as internal control to ensure equal loading of samples. It is estimated by densitometry that 75% of phosphotyrosine from RPTPC1060S was removed by addition of RPTPĪ³ enzyme.</p
Determination of Km of phosphatase RPTPĪ³ on peptide substrate ATQDD(pY)VLEVR (derived from peptide adjacent to Y1307).
<p>Figure here shows Pi released (microM per minute) was plotted against phospho-peptide in a reaction in which Vmax was 2.1 ĀµM/mim/14 nM RPTPĪ³ and Km is 49.6 ĀµM, using one site nonlinear binding algorithm in Graphpad Prism.</p